Le Registre des lobbyistes

Registration - In-house Corporation

Hoffmann-La Roche Limited / BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER

Registration Information

In-house Corporation name: Hoffmann-La Roche Limited
Previous in-house corporation names
Responsible Officer Name: BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER 
Responsible Officer Change History
Initial registration start date: 2001-01-18
Registration status: Active
Registration Number: 952745-64

Associated Communications

Total Number of Communication Reports: 452

Monthly communication reports in the last 6 months: 21

Version 7 of 65 (2007-05-31 to 2007-12-20)

Version 7 of 65 (2007-05-31 to 2007-12-20) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Hoffmann-La Roche Limited
2455 Meadowpine Blvd.
Mississauga, ON  L5N 6L7
Canada
Telephone number: 905-542-5555
Fax number: 905-542-7130  
Responsible officer name and position during the period of this registration: RONNIE MILLER, PRESIDENT AND CEO  
Description of activities: Hoffmann-La Roche Limited deals with the healthcare system in the diagnosis, treatment and management of acute and long-term disease and supports leading research and development - including clinical research, clinical trials and genetic research.
 
The client is a subsidiary of the following parent companies: F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basle
Switzerland

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Linnea Doyle
Position title: Director of Market Access
Public offices held: No
 
Name: Brigitte Nolet
Position title: Director, Federal Health Policy and Government Relations
Public offices held: Yes
 
Name: Jamie Slater
Position title: Product Manager
Public offices held: No
 
Name: Ilona Torontali
Position title: Vice President, Public Affairs
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Affaires autochtones et Développement du Nord Canada, Affaires étrangères et Commerce international Canada (MAECIC), Agence canadienne de développement international (ACDI), Agence de promotion économique du Canada atlantique (APECA), Agence spatiale canadienne (ASC), Agriculture et Agroalimentaire Canada (AAC), Anciens Combattants Canada (ACC), Bureau du Conseil privé (BCP), Bureau fédéral de développement régional (Québec) (BFDR[Q]), Cabinet du Premier ministre (CPM), Citoyenneté et Immigration Canada, Commissaire à l'information et à la protection de la vie privée (CIPVP), Commission de la fonction publique du Canada (CFP), Conseil d'examen du prix des médicaments brevetés (CEPMB), Conseil de recherches en sciences naturelles et en génie (CRSNG), Conseil national de recherches (CNRC), Défense nationale (MDN), Députés de la Chambre des communes, Développement des ressources humaines Canada (DRHC), Diversification de l'économie de l'Ouest Canada (DEO), Environnement Canada, Finances Canada (FIN), Gendarmerie royale du Canada (GRC), Industrie Canada, Justice Canada (JC), Office national des transports (ONT), Office of the Auditor General, Ressources naturelles Canada (RNCan), Revenu Canada (RC), Santé Canada (SC), Secrétariat du Conseil du Trésor du Canada (SCT), Sécurité publique et Protection civile Canada (SPPCC), Sénat du Canada, Service Canada (ServCan), Service correctionnel du Canada (SCC), Solliciteur général Canada (SGC), Statistique Canada (StatCan), Transports Canada (TC), Travaux publics et Services gouvernementaux Canada, Tribunal canadien du commerce extérieur (TCCE), Tribunal de la concurrence (TC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Appels téléphoniques, Communications écrites, en format papier ou électronique, Présentations, Réunions
 
Subject Matter: Areas of Concern: Affaires autochtones, Agriculture, Commerce intérieur, Commerce international, Défense, Développement régional, Éducation, Emploi et formation, Énergie, Environnement, Foresterie, Immigration, Impôts et finances, Industrie, Infrastructure, Institutions financières, Justice et application des lois, Marchés publics, Pêches, Petites entreprises, Propriété intellectuelle, Questions constitutionnelles, Questions touchant les consommateurs, Relations internationales, Santé, Sciences et technologies, Sports, Transports, Travail
 
Objets poursuivis : Renseignements rétrospectifs : Industry Canada: political/bureaucrat - Science and Technology Strategy, Patented Medicines (PM) Notice of Compliance (NOC) regulations, Budget, issues affecting health and pharmaceutical industries, Pharma Partnering, international aid programs and biotechnology. Health Canada: Science and Technology Strategy, PM (NOC) regulations, data protection, pandemic planning, international aid programs.
Objets poursuivis : Renseignements prospectifs : Treasury Board: Smart Regulations, pandemic planning Industry Canada: Science and Technology Strategy, PM (NOC) regulations, Patent Act, pharmaceutical and biotechnology R&D issues, smart regulations, patent policy, lifesciences industry, biosimilars, international aid programs, and pharma partnering.Health Canada: drug safety, data protection regulations, innovation issues, drug approval, counterfeit drugs, pandemic planning, international aid programs, and national pharmaceutical strategy. Foreign Affairs/Trade: ongoing international issues, patent issues, access and benefit sharing issues, international aid programs. Finance: Budget/budget update CIDA: international aid programs
 

Détails sur l'objet indiqué

Catégories Description
Politique ou programme access and benefit sharing issues
Politique ou programme Canada's Access to Medicines Regime
Règlement data protection regulations
Politique ou programme, Projet de loi ou résolution Food and Drugs Act
Politique ou programme international aid programs
Politique ou programme international pharmaceutical issues
Politique ou programme lifesciences trends
Politique ou programme national pharmaceutical strategy
Politique ou programme pandemic planning
Projet de loi ou résolution Patent Act
Politique ou programme Patented Medicine Prices Review Board Pricing Guidelines
Politique ou programme patent policy
Politique ou programme pharmaceutical and biotechnology R&D issues
Règlement PM (NOC) regulations
Politique ou programme Science and Technology Strategy
Politique ou programme smart regulations
Règlement, Politique ou programme Subsequent Entry Biologics




Date de la dernière version :